Figure 2.
Cyclin G2 (CCNG2) expression in primary pancreatic cancer samples, observed by immunohistochemical staining. CCNG2-positive cases demonstrated a (A) diffused or (B) spotted nuclear pattern; by contrast, CCNG2-negative cases exhibited a (C) cytoplasmic pattern (no staining in the nucleus) or (D) negative pattern (no staining in the nucleus or cytoplasm).